Replies to post #143666 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

I actually read the 8-K - the S-1 - the S-1A and the 424B3...

In the 424B3 - in the first paragraph it states:

"47,500,000 Shares of Common stock

This prospectus relates to the offer and sale from time to time of up to 47,500,000 shares of our common stock by the selling stockholder listed on page 61 of this prospectus. The number of shares offered for sale by the selling stockholder consists of up to (i) 140% of the 25,000,000 shares (or 35,000,000 shares) of our common stock currently issuable upon the conversion of 500 shares of our new series of preferred stock designated as Series A Preferred Stock (the “Series A Preferred Shares”) held by the selling stockholder and (ii) 12,500,000 shares of our common stock currently issuable upon exercise of a warrants held by the selling stockholder (the “Warrants”). The selling stockholder acquired the Preferred Shares and the Warrants from us pursuant to a Securities Purchase Agreement (the “Securities Purchase Agreement”), dated April 30, 2018, by and between the Company and the investor identified therein (the “Investor").

As you can see OWCP is authorizing 47,500,000 shares to be registered.

And I am certain you don't understand the Warrants - as can be seen by the copy and paste from Wikipedia.

A stock warrant is simply a contract to allow someone/company buy stock at a pre-determined price - it is a very simple process.

Remember the pre-determined price can include variables such as a discount that is calculated by the terms of the contract (Equity Purchase Agreement).

I have a in depth understanding of warrants.

IG